Literature DB >> 2871579

Chronic use of benzodiazepines and psychomotor and cognitive test performance.

I Lucki, K Rickels, A M Geller.   

Abstract

The performance of 43 long-term users (average = 5 years) of benzodiazepine (BZ) medications was examined on a battery of behavioral tasks, cognitive tests, and subjective mood rating scales. The performance of the chronic BZ users did not differ significantly from age- and sex-matched anxious subjects, except that critical flicker fusion (CFF) thresholds were lower and subjective ratings of tranquilization were higher in the BZ users. Twenty-two subjects were reexamined in order to determine the acute effects of BZ medications in long-term users. The acute administration of BZ medications significantly increased CFF thresholds, improved digit-symbol substitution test performance, impaired the delayed recall of verbal material, increased subjective ratings of tranquilization, and reduced physical sedation. Motor performance tests were not impaired and subjective feelings of sedation were not increased after the acute administration of BZs by chronic users. During withdrawal from long-term BZ use (17 subjects), CFF thresholds were elevated, subjective ratings of physical sedation and anxiety were increased, but performance on other psychomotor and cognitive tests was not altered. The results suggest that tolerance develops selectively to different behavioral and subjective effects of BZ medications with their continued use. Tolerance failed to develop to the antianxiety effects, the reduction of CFF threshold, and to the impairment of short-term memory caused by BZs. However, chronic users of BZ medications failed to demonstrate psychomotor-impairing or sedating effects to BZ medications. The results have implications for evaluating the safety of the long-term use of BZ medications.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2871579     DOI: 10.1007/bf00178503

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  33 in total

1.  The action of sedatives on brain stem oculomotor systems in man.

Authors:  H Norris
Journal:  Neuropharmacology       Date:  1971-03       Impact factor: 5.250

2.  Concreteness, imagery, and meaningfulness values for 925 nouns.

Authors:  A Paivio; J C Yuille; S A Madigan
Journal:  J Exp Psychol       Date:  1968-01

3.  Memory problems after ischemic heart disease episodes: effects of stress, benzodiazepines and smoking.

Authors:  N Frasure-Smith; E Rolicz-Woloszyk
Journal:  J Psychosom Res       Date:  1982       Impact factor: 3.006

4.  Development of tolerance and cross-tolerance to the psychomotor actions of lorazepam and diazepam in man.

Authors:  K Aranko; M J Mattila; T Seppälä
Journal:  Br J Clin Pharmacol       Date:  1983-05       Impact factor: 4.335

5.  A clinical appraisal of diazepam.

Authors:  S Cohen
Journal:  Psychosomatics       Date:  1981-09       Impact factor: 2.386

6.  Diazepam and memory: retrograde facilitation produced by interference reduction.

Authors:  J V Hinrichs; M M Ghoneim; S P Mewaldt
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

7.  Psychometric performance during withdrawal from long-term benzodiazepine treatment.

Authors:  H Petursson; G H Gudjonsson; M H Lader
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

8.  Psychological performance in anxious patients treated with diazepam.

Authors:  C Zimmermann-Tansella; M Tansella; M Lader
Journal:  Prog Neuropsychopharmacol       Date:  1979

9.  Impaired performance and sedation after a single dose of lorazepam.

Authors:  S E File; A J Bond
Journal:  Psychopharmacology (Berl)       Date:  1979       Impact factor: 4.530

10.  A comparison of cognitive impairment due to benzodiazepines and to narcotics.

Authors:  N Hendler; C Cimini; T Ma; D Long
Journal:  Am J Psychiatry       Date:  1980-07       Impact factor: 18.112

View more
  30 in total

1.  Dissociation between the effects of benzodiazepine receptor agonists on behavioral vigilance and responsitivity.

Authors:  P Dudchenko; B Paul; M Sarter
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

2.  Acute reversal of flunitrazepam effects by Ro 15-1788 and Ro 15-3505: inverse agonism, tolerance, and rebound.

Authors:  V Gentil; S Tavares; C Gorenstein; C Bello; L Mathias; G Gronich; J Singer
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

3.  A placebo-controlled study of effects of oral progesterone on performance and mood.

Authors:  E W Freeman; L Weinstock; K Rickels; S J Sondheimer; C Coutifaris
Journal:  Br J Clin Pharmacol       Date:  1992-03       Impact factor: 4.335

Review 4.  Drug-induced cognition disorders in the elderly: incidence, prevention and management.

Authors:  S L Gray; K V Lai; E B Larson
Journal:  Drug Saf       Date:  1999-08       Impact factor: 5.606

Review 5.  A Review of Alprazolam Use, Misuse, and Withdrawal.

Authors:  Nassima Ait-Daoud; Allan Scott Hamby; Sana Sharma; Derek Blevins
Journal:  J Addict Med       Date:  2018 Jan/Feb       Impact factor: 3.702

6.  Benzodiazepine prescriptions and therapist non-compliance.

Authors:  B Geiselmann; M Linden; N Sachs-Ericsson
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989

7.  Evaluation in rats of the somnogenic, pyrogenic, and central nervous system depressant effects of muramyl dipeptide.

Authors:  L T Meltzer; K A Serpa; W H Moos
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

8.  Dissociation of benzodiazepine-induced amnesia from sedation by flumazenil pretreatment.

Authors:  D Hommer; H Weingartner; A Breier
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

9.  Like diazepam, CL 218,872, a selective ligand for the benzodiazepine omega 1 receptor subtype, impairs place learning in the Morris water maze.

Authors:  R K McNamara; R W Skelton
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

10.  Amnesic effects and subjective ratings during repeated dosing of flunitrazepam to healthy volunteers.

Authors:  J Ingum; K M Beylich; J Mørland
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.